Virtual Reality for Anxiety Relief in Infertile Women
Launched by CYPRUS AYDIN UNIVERSITY · Jun 12, 2025
Trial Information
Current as of November 05, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is asking whether using virtual reality (VR) glasses, with calming Zen music and nature scenery, can help reduce anxiety for women going through embryo transfer as part of infertility treatment. In this randomized trial, 80 adult women (ages 18–50) with primary infertility will be split into two groups: 40 will use the VR experience before and after the embryo transfer, and 40 will receive the usual care without VR. The study is designed so that participants don’t know which group they’re in. Anxiety will be measured before and after the procedure using a standard questionnaire to see if the VR experience lowers anxiety.
Who can participate: women aged 18–50 who are undergoing embryo transfer for primary infertility. They should be able to read and write, have no major vision or hearing problems, not have a current mental health disorder, and not have secondary infertility or recent complications like miscarriage after embryo transfer. The study is being conducted at Cyprus Aydin University in Girne, Cyprus, and is anticipated to finish around March 2026. This is a doctoral research project and, at this stage, does not involve FDA-regulated drugs or devices or sharing individual data. If you’re interested, talk to the study team, led by Nazli Catak.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Volunteered to participate in the research,
- • 18-50 years old
- • No vision and hearing problems,
- • Not disoriented in time and place,
- • Primary infertile
- • Not having communication problem
- • Can read \& write
- • No mental pathological disease
- Exclusion Criteria:
- • Secondary infertility
- • Having experienced bleeding, miscarriage, etc. after embryo transfer,
- • Difficulty communicating,
- • Problems such as migraine, vertigo, dizziness,
- • Patients who wear prescription glasses and have vision problems without glasses
- • Refused to participate in the research
- • Patients with psychiatric pathology
About Cyprus Aydin University
Cyprus Aydin University is a dynamic educational institution committed to advancing research and innovation in the fields of health sciences and beyond. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to facilitate groundbreaking research initiatives aimed at improving patient outcomes and enhancing medical knowledge. With a focus on ethical practices and rigorous scientific methodologies, Cyprus Aydin University collaborates with a diverse range of stakeholders, including healthcare professionals and industry partners, to ensure the successful execution of clinical trials that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Girne Kepuveia, Girne, Cyprus
Patients applied
Trial Officials
NAZLI CATAK, MSc
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported